Promethean Fires Up AC-11 Cosmeceutical Line With Optigenex Deal
This article was originally published in The Rose Sheet
Executive Summary
Promethean Corporation aims to launch nutritional supplements and a topical skin-care system in 2010 under a deal with Optigenex granting it access to the latter's AC-11 compound for DNA repair